Clinical Trial Update: Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating aprotinin for acute respiratory distress syndrome, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Aprotinin (aprotinin)

Snippet

Sponsor: Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion | Conditions: Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Status: NOT_YET_RECRUITING